Matching for the D antigen in haematopoietic progenitor cell transplantation: Definition and clinical outcomes

Blood Transfusion

Volumn 12, Issue 3, 2014, Pages 301-306

  Cid, Joan ^a,b   Lozano, Miguel ^a   Klein, Harvey G ^b   Flegel, Willy A ^b  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

D antigen; Haematopoietic progenitor cell; Incompatibility; Mismatching; Transplantation

Indexed keywords

AUTOANTIBODY; HLA D ANTIGEN; RHESUS D ANTIGEN; BLOOD GROUP ABO SYSTEM; BLOOD GROUP RHESUS SYSTEM; RHO(D) ANTIGEN;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP RHESUS SYSTEM; GENE; GENE DELETION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; MORBIDITY; REVIEW; RHD GENE; SURVIVAL; ALLOGRAFT; BLOOD; BLOOD GROUP ABO SYSTEM; BLOOD GROUP TYPING; HISTOCOMPATIBILITY TEST; PROCEDURES;

ABO BLOOD-GROUP SYSTEM; ALLOGRAFTS; BLOOD GROUPING AND CROSSMATCHING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; RH-HR BLOOD-GROUP SYSTEM;

EID: 84904693669     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2014.0238-13     Document Type: Review

References (24)

1. Rowley SD. Hematopoietic stem cell transplantation between red cell incompatible donor-recipient pairs. Bone Marrow Transplant 2001; 28: 315-21. (Pubitemid 32834347)
2. O'Donghaile D, Kelley W, Klein HG, Flegel WA. Recommendations for transfusion in ABO-incompatible hematopoietic stem cell transplantation. Transfusion 2012; 52: 456-8.
3. Daniel-Johnson J, Schwartz J. How do I approach ABO-incompatible hematopoietic progenitor cell transplantation? Transfusion 2011; 51: 1143-9.
4. Chan JY, Tokessy M, Saidenberg E, et al. Rh D alloimmunization in allogeneic HSCT. Bone Marrow Transplant 2013; 48: 459-60.
5. Franchini M, Gandini G, Aprili G. Non-ABO red blood cell alloantibodies following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2004; 33: 1169-72. (Pubitemid 38961472)
6. Tormey CA, Stack G. The persistence and evanescence of blood group alloantibodies in men. Transfusion 2009; 49: 505-12.
7. Lasky LC, Warkentin PI, Kersey JH, et al. Hemotherapy in patients undergoing blood group incompatible bone marrow transplantation. Transfusion 1983; 23: 277-85. (Pubitemid 13035881)
8. Hows J, Beddow K, Gordon-Smith E, et al. Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation. Blood 1986; 67: 177-81. (Pubitemid 16167029)
9. Ting A, Pun A, Dodds AJ, et al. Red cell alloantibodies produced after bone marrow transplantation. Transfusion 1987; 27: 145-7. (Pubitemid 17101777)
10. Mijovic A. Alloimmunization to RhD antigen in RhD-incompatible haemopoietic cell transplants with nonmyeloablative conditioning. Vox Sang 2002; 83: 358-62. (Pubitemid 35434359)
11. Erker CG, Steins MB, Fischer RJ, et al. The influence of blood group differences in allogeneic hematopoietic peripheral blood progenitor cell transplantation. Transfusion 2005; 45: 1382-90. (Pubitemid 41647807)
12. Cid J, Lozano M, Fernandez-Aviles F, et al. Anti-D alloimmunization after D-mismatched allogeneic hematopoietic stem cell transplantation in patients with hematologic diseases. Transfusion 2006; 46: 169-73. (Pubitemid 43381749)
13. Wirk B, Klumpp TR, Ulicny J, et al. Lack of effect of donor-recipient Rh mismatch on outcomes after allogeneic hematopoietic stem cell transplantation. Transfusion 2008; 48: 163-8.
14. Worel N, Bohm A, Rabitsch W, et al. Frequency and prognostic value of D alloantibodies after D-mismatched allogeneic hematopoietic stem cell transplantation after reduced-intensity conditioning. Transfusion 2012; 52: 1348-53.
15. Esteve J, Alcorta I, Pereira A, et al. Anti-D antibody of exclusive IgM class after minor Rh(D)-mismatched BMT. Bone Marrow Transplant 1995; 16: 632-3.
16. Franchini M, de Gironcoli M, Gandini G, et al. Transmission of an anti-RhD alloantibody from donor to recipient after ABO-incompatible BMT. Bone Marrow Transplant 1998; 21: 1071-3. (Pubitemid 28230675)
17. Berkman EM, Caplan SN. Engraftment of RH-positive marrow in a recipient with RH antibody. Transplant Proc 1977; 9: 215-8. (Pubitemid 8070260)
18. Rigal D, Monestier M, Meyer F, et al. Transplant of rhesus-positive bone marrow in a rhesus-negative woman having anti-rhesus D alloantibodies. Acta Haematol 1985; 73: 153-6. (Pubitemid 15003520)
19. Sokol RJ, Stamps R, Booker DJ, et al. Posttransplant immunemediated hemolysis. Transfusion 2002; 42: 198-204.
20. Daikeler T, Labopin M, Ruggeri A, et al. New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation. Blood 2013; 121: 1059-64.
21. Kumar S, Zhang MJ, Li P, et al. Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis. Blood 2011; 118: 1979-88.
22. Majhail NS, Rizzo JD, Lee SJ, et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Hematol Oncol Stem Cell Ther 2012; 5: 1-30.
23. Tormey CA, Fisk J, Stack G. Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans. Transfusion 2008; 48: 2069-76.
24. Girelli G, Arcese W, Bianchi A, et al. Hemolysis in Rh-negative female recipient after Rh-incompatible bone marrow transplantation for chronic myeloid leukemia. Haematologica 1986; 71: 46-9. (Pubitemid 16144472)